Formulation and In-Vitro Characterization of Acyclovir Floating Matrix Tablets: A Factorial Design Study.
Loading...
Date
2013-05
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
The objective of present study was to develop controlled release floating matrix tablets of Acyclovir using
combination of release retarding polymers: hydroxypropyl methylcellulose (HPMC K15M CR) and polyethylene
oxide (Polyox WSR 303) for treatment of herpes infections using direct compression technique. The influence of
type of polymer and its concentration on the drug release from prepared floating tablets was investigated using a
32 factorial design. Independent variables selected were concentration of Polyox WSR 303 (X1) and HPMC
K15M CR (X2) while dependent variables were percentage cumulative drug release at 3, 9 and 12 h (Q3, Q9, and
Q12). Analysis of variance (ANOVA) and multiple regression analysis showed significant effect on Q3, Q9, and
Q12. Formulations also contained sodium bicarbonate (NaHCO3) and anhydrous citric acid as floating agent,
polyvinyl pyrrolidone (PVP K30) as dry binder and microcrystalline cellulose (MCC, Avicel PH 102) as diluent.
The floating tablets were evaluated for their floating lag time (FLT), floating duration, hardness, friability, weight
variation, and in-vitro drug release, dissolution efficiency and accelerated stability study. F2 with Polyox WSR
303 (50 mg) and HPMC K15M CR (15 mg) gave best results. Stability study revealed optimized formulation F2
to remain stable. A controlled release floating matrix tablet of Acyclovir was successfully prepared by using
Polyox WSR 303 and HPMC K15M CR.
Description
Keywords
Acyclovir, Floating matrix tablet, HPMC K15M CR, Polyox WSR 303.
Citation
Shahi Sadhana, Sonawane Ashok, Vanamore Suhas, Zadbuke Nityanand. Formulation and In-Vitro Characterization of Acyclovir Floating Matrix Tablets: A Factorial Design Study. Journal of Applied Pharmaceutical Science. 2013 May; 3(5): 65-74.